Joint effect of peroxisome proliferator-activated receptor γ genetic polymorphisms and estrogen-related risk factors on breast cancer risk: results from a case–control study in Taiwan (Q39808231)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 8, 2010

Language	Label	Description	Also known as
English	Joint effect of peroxisome proliferator-activated receptor γ genetic polymorphisms and estrogen-related risk factors on breast cancer risk: results from a case–control study in Taiwan	scientific article published on December 8, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Joint effect of peroxisome proliferator-activated receptor γ genetic polymorphisms and estrogen-related risk factors on breast cancer risk: results from a case-control study in Taiwan (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Joint effect of peroxisome proliferator-activated receptor γ genetic polymorphisms and estrogen-related risk factors on breast cancer risk: results from a case–control study in Taiwan (English)

1 reference

10.1007/S10549-010-1282-4

https://api.crossref.org/works/10.1007/S10549-010-1282-4

19 November 2024

single-nucleotide polymorphism

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21140205

19 November 2024

author name string

Mei-Hsuan Wu

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Chi-Hong Chu

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Yu-Ching Chou

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Wan-Yun Chou

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Tsan Yang

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Giu-Cheng Hsu

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Cheng-Ping Yu

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Jyh-Cherng Yu

8

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Chien-An Sun

9

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

language of work or name

0 references

publication date

8 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

full work available at URL

http://link.springer.com/content/pdf/10.1007/s10549-010-1282-4.pdf

Portable Document Format

1 reference

10.1007/S10549-010-1282-4

https://api.crossref.org/works/10.1007/S10549-010-1282-4

19 November 2024

http://link.springer.com/article/10.1007/s10549-010-1282-4/fulltext.html

1 reference

10.1007/S10549-010-1282-4

https://api.crossref.org/works/10.1007/S10549-010-1282-4

19 November 2024

http://link.springer.com/content/pdf/10.1007/s10549-010-1282-4

1 reference

10.1007/S10549-010-1282-4

https://api.crossref.org/works/10.1007/S10549-010-1282-4

19 November 2024

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

127

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

777-784

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

Obesity, adipocytokines, and insulin resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

PPARgamma, the ultimate thrifty gene

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

Peroxisome proliferator-activated receptors: nuclear control of metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

The mechanisms of action of PPARs

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

Peroxisome proliferator-activated receptor gamma (PPargamma) as a novel target for prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

Terminal differentiation of human breast cancer through PPAR gamma

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

A functional polymorphism in a STAT5B site of the human PPAR gamma 3 gene promoter affects height and lipid metabolism in a French population

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

Circulating levels of leptin, adiposity and breast cancer risk

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

Relationships between critical period of estrogen exposure and circulating levels of insulin-like growth factor-I (IGF-I) in breast cancer: evidence from a case-control study

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

Hormonal and body-size factors in relation to breast cancer risk: a prospective study of 11,889 women in a low-incidence area

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

Haploview: analysis and visualization of LD and haplotype maps

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

Lack of association of the codon 12 polymorphism of the peroxisome proliferator-activated receptor gamma gene with breast cancer and body mass

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

Peroxisome proliferator-activated [corrected] receptor-gamma2 [corrected] Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

Estrogen carcinogenesis in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

Unique features of breast cancer in Asian women--breast cancer in Taiwan as an example.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

Opposite association of two PPARG variants with cancer: overrepresentation of H449H in endometrial carcinoma cases and underrepresentation of P12A in renal cell carcinoma cases

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1282-4

21 January 2018

A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions

10

1 reference

10.1007/S10549-010-1282-4

https://api.crossref.org/works/10.1007/S10549-010-1282-4

19 November 2024

Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions

13

1 reference

10.1007/S10549-010-1282-4

https://api.crossref.org/works/10.1007/S10549-010-1282-4

19 November 2024

Two Polymorphisms in the Peroxisome Proliferator-Activated Receptor- Gene Are Associated with Severe Overweight among Obese Women

17

1 reference

10.1007/S10549-010-1282-4

https://api.crossref.org/works/10.1007/S10549-010-1282-4

19 November 2024

Selection of controls in case-control studies. I. Principles

34

1 reference

10.1007/S10549-010-1282-4

https://api.crossref.org/works/10.1007/S10549-010-1282-4

19 November 2024

Identifiers

10.1007/S10549-010-1282-4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39808231&oldid=2277044844"